Gepotidacin was approved by the FDA earlier this year, under the Blujepa brand, as the first oral antibiotic to offer a new ...

The word from the FDA is that Prasad has come back at the request of the regulator's Commissioner, Marty Makary, who ...

Haematological cancers are a recognised potential side effect with Skysona and were already mentioned in a boxed warning on ...

One major and often overlooked factor contributing to this imbalance is the way health outcomes are measured in clinical ...

One near-term rival is Johnson & Johnson's FcRn inhibitor nipocalimab, which started a phase 3 programme last December.

Boehringer Ingelheim's bid to return to the oncology arena has been achieved with an FDA approval for Hernexeos, a new, ...

The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...

It was that same signal-based approach that we found can be applied to cancer research. A potential new approach to ...

Strand Therapeutics has raised $153 million in second-round financing that will be used to move its programmable mRNA ...

Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 ...

A jury in the US has found that tech giant Meta illegally compromised the privacy of a US woman who shared her data with a ...

The joint information sharing agreement between the medicines regulatory authority and reimbursement agency was first ...